Co-beneldopa (Benserazide/levodopa) Prescribing at PHOENIX HEALTH GROUP
Drugs used in parkinsonism and related disorders | Central Nervous System
Items (12m)
456
Total Quantity
51.3K
NHS Cost
£3.6K
vs National Avg
+201.7%
PHOENIX HEALTH GROUP prescribed 456 items of Co-beneldopa (Benserazide/levodopa) over the last 12 months at a cost of £3,620 to the NHS. This is 201.7% above the national average prescribing rate. Co-beneldopa (Benserazide/levodopa) is classified under Drugs used in parkinsonism and related disorders in the BNF.
Monthly Prescribing Trend
Jul 2026
39
Jul 2026
39
Jul 2026
36
Jul 2026
34
Jul 2026
39
Jul 2026
37
Jul 2026
31
Jul 2026
38
Jul 2026
41
Jul 2026
41
Jul 2026
37
Jul 2026
44
Prescribing Details
| Total Items | 456 |
|---|---|
| Total Quantity | 51,300 |
| Total NHS Cost | £3,620 |
| Presentations | 11 different forms |
| vs National Average | +201.7% |
Co-beneldopa (Benserazide/levodopa) Prescribing Comparison
| This practice | 456 items |
|---|---|
| National average per practice | 151 items |
| Difference | +201.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.